Dysregulation of iron and renal anemia treatment in patients with chronic kidney disease

Not Applicable

Recruiting

• Conditions: Patients with chronic kidney disease

• Registration Number: JPRN-UMIN000011949
• Lead Sponsor: Hyogo College of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-10-03
• Study Completion: 2014-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

malignancy and inflammatory, gastro-intestinal, hepatic, and bone marrow diseases

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Factors related to iron regulation: serum iron, transferrin saturation rate, ferritin, frataxin et al. Factors related to oxidative stress: malondialdehyde, 8OHdG, AOPP, pentosidine, GSH et al.

Secondary Outcome Measures

Name	Time	Method
Factors related to inflammation: high-sensitivity CRP, interleukin-6, tumor necrosis factors-alpha, pentraxin, troponin T, et al. Factors related to nutrition: BMI, albumin, prealbumin et al.